In RA synovial fibroblasts, CCL19 expression is primarily modulated by lipopolysaccharide (LPS), tumor necrosis factor-α (TNF-α), interleukin-1 beta (IL-1β) and IL-8, whereas CCL21 is modulated by TNF-α. Here, CXCL8 is linked to rheumatoid arthritis.